DRY POWDER INHALER AND NEBULIZER APPLICATIONS
Accelerate your product development and approvals by providing the information necessary for predictive clinical outcomes and bioequivalence.
Our new INVIDA™ Platform lets you measure the aerosol dispersion and regional deposition of inhaled drugs under human-realistic breathing profiles. A valuable tool for understanding your product’s in vivo performance, the innovative technology gives you a visual map of your product within the respiratory tract, as well as quantitative measurements of drug deposition. Applications include: